Menu

Intellia Therapeutics, Inc. (NTLA) Discusses Lonvo-z Clinical Data and Commercial Launch Preparations in HAE Transcript
📰

Intellia Therapeutics, Inc. (NTLA) Discusses Lonvo-z Clinical Data and Commercial Launch Preparations in HAE Transcript

All Articles on Seeking Alpha·3 days ago
#lg2O0HT4
Reading 0:00
15s threshold

Intellia Therapeutics, Inc. ( NTLA ) Discusses Lonvo-z Clinical Data and Commercial Launch Preparations in HAE November 12, 2026 10:00 AM EST

Company Participants

Jason Fredette - Vice President of Investor Relations & Corporate Communications

John Leonard - President, CEO & Director

Jing Marantz - EVP & Chief Medical Officer

Maria Natale - Senior Vice President of Commercial

Fred Cohen

Conference Call Participants

Marc Riedl

Danny Cohn

Joseph Thome - TD Cowen, Research Division

Jonathan Miller - Evercore ISI Institutional Equities, Research Division

Silvan Tuerkcan - Citizens JMP Securities, LLC, Research Division

Alec Stranahan - BofA Securities, Research Division

Maurice Raycroft - Jefferies LLC, Research Division

Lut Ming Cheng - JPMorgan Chase & Co, Research Division

Jeffrey Stith - Wells Fargo Securities, LLC, Research Division

John Boyle - William Blair & Company L.L.C., Research Division

Binita Shah

Andy Chen - Wolfe Research, LLC

Jasmine Fels - Barclays Bank PLC, Research…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.